AU2005273726A1 - Arene ruthenium (II) compounds and their use in cancer therapy - Google Patents

Arene ruthenium (II) compounds and their use in cancer therapy Download PDF

Info

Publication number
AU2005273726A1
AU2005273726A1 AU2005273726A AU2005273726A AU2005273726A1 AU 2005273726 A1 AU2005273726 A1 AU 2005273726A1 AU 2005273726 A AU2005273726 A AU 2005273726A AU 2005273726 A AU2005273726 A AU 2005273726A AU 2005273726 A1 AU2005273726 A1 AU 2005273726A1
Authority
AU
Australia
Prior art keywords
compound according
alkyl
carbocyclic
compound
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005273726A
Other languages
English (en)
Inventor
Abraha Habtemariam
Peter John Sadler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Edinburgh
Original Assignee
University of Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Edinburgh filed Critical University of Edinburgh
Publication of AU2005273726A1 publication Critical patent/AU2005273726A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046—Ruthenium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2005273726A 2004-08-20 2005-08-19 Arene ruthenium (II) compounds and their use in cancer therapy Abandoned AU2005273726A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0418643.3 2004-08-20
GBGB0418643.3A GB0418643D0 (en) 2004-08-20 2004-08-20 Ruthenium (II) compounds
PCT/GB2005/003242 WO2006018649A1 (en) 2004-08-20 2005-08-19 Arene ruthenium (ii) compounds and their use in cancer therapy

Publications (1)

Publication Number Publication Date
AU2005273726A1 true AU2005273726A1 (en) 2006-02-23

Family

ID=33042406

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005273726A Abandoned AU2005273726A1 (en) 2004-08-20 2005-08-19 Arene ruthenium (II) compounds and their use in cancer therapy

Country Status (12)

Country Link
EP (1) EP1786412A1 (https=)
JP (1) JP2008510693A (https=)
KR (1) KR20070060091A (https=)
CN (1) CN101043885A (https=)
AU (1) AU2005273726A1 (https=)
BR (1) BRPI0514430A (https=)
CA (1) CA2578280A1 (https=)
GB (1) GB0418643D0 (https=)
MX (1) MX2007002099A (https=)
NO (1) NO20071481L (https=)
WO (1) WO2006018649A1 (https=)
ZA (1) ZA200702093B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006017594A1 (de) * 2006-04-13 2007-10-18 Wacker Chemie Ag Neuartige Ru-Komplexe, deren Herstellung und Verwendung
US9018199B2 (en) 2006-05-09 2015-04-28 Ecole Polytechnique Federale De Lausanne (Epfl) Transition metal complexes for inhibiting resistance in the treatment of cancer and metastasis
GB0711849D0 (en) * 2007-06-19 2007-07-25 Oxford Biosensors Ltd Redox Mediators
EP2067771A1 (en) 2007-12-03 2009-06-10 EPFL Ecole Polytechnique Fédérale de Lausanne Derivatives of Dihydroxypyrrolidine as Anti-Cancer Compounds
EP2409697A1 (en) 2010-07-20 2012-01-25 Université de Neuchâtel Medicaments Based on Dinuclear Ruthenium, Osmium and Iron Complexes Comprising Triply Bridging Thiolato, Selenolato, Alkoxo and/or Amido Ligands
WO2013038395A1 (en) 2011-09-16 2013-03-21 Universidade De Lisboa Transition metal complexes for pharmaceutical applications
WO2013136296A2 (en) 2012-03-14 2013-09-19 Universidade De Lisboa Water-soluble organometallic ruthenium and iron compunds presenting heteroaromatic ligands
BR112015023568B8 (pt) 2013-03-15 2024-01-02 Ann Mcfarland Sherri Composto à base de metal como composto fotodinâmico
US9751081B2 (en) 2014-12-01 2017-09-05 Clemson University Self-regenerating antioxidant catalysts and methods of using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19736152A1 (de) * 1997-08-14 1999-02-18 Martin Wehlan Azido-Aziridinkomplexe, Verfahren zu ihrer Herstellung und ihre Verwendung
JP2003512471A (ja) * 1999-10-27 2003-04-02 ユニバーシティ コート， エディンバラ大学 窒素および配位子を含む癌治療用の半サンドイッチ状ルテニウム（ｉｉ）化合物
GB0016052D0 (en) * 2000-06-30 2000-08-23 Univ Edinburgh Ruthenium (II) compounds
GB0215526D0 (en) * 2002-07-05 2002-08-14 Univ Edinburgh Anticancer compounds

Also Published As

Publication number Publication date
KR20070060091A (ko) 2007-06-12
GB0418643D0 (en) 2004-09-22
CA2578280A1 (en) 2006-02-23
MX2007002099A (es) 2007-04-24
WO2006018649A1 (en) 2006-02-23
EP1786412A1 (en) 2007-05-23
NO20071481L (no) 2007-05-16
CN101043885A (zh) 2007-09-26
JP2008510693A (ja) 2008-04-10
BRPI0514430A (pt) 2008-05-06
ZA200702093B (en) 2008-08-27

Similar Documents

Publication Publication Date Title
KR102942706B1 (ko) 에스트로겐 수용체 분해 활성을 갖는 신규한 크로만 유도체 및 이의 용도
Pellei et al. Synthesis and biological activity of ester-and amide-functionalized imidazolium salts and related water-soluble coinage metal N-heterocyclic carbene complexes
EP1991556A1 (en) Ruthenium (ii) compounds
KR101059183B1 (ko) 피롤로벤조디아제핀
EP2146977B1 (en) Synthesis of cyclic carbonates in the presence of dimeric aluminium (salen) catalysts
AU2005273726A1 (en) Arene ruthenium (II) compounds and their use in cancer therapy
Khalid et al. Structure and surface analyses of a newly synthesized acyl thiourea derivative along with its in silico and in vitro investigations for RNR, DNA binding, urease inhibition and radical scavenging activities
US20090186864A1 (en) Ruthenium (ii) compounds
US20080096846A1 (en) Arene Ruthenium (ll) Compounds And Their Use In Cancer Therapy
JP6985764B2 (ja) アミノピリミジン系化合物、この化合物を含む組成物およびそれらの使用
Pörschke Coupling of Two Ethyne Molecules at a Nickel Center to Form a Nickelacyclopentadiene Complex
WO2010024783A1 (en) Biarylrhodanine and pyridylrhodanine compounds and their use
JP5015451B2 (ja) ホスフィン遷移金属錯体、その製造方法およびそれを含有する抗癌剤
JP5646606B2 (ja) 抗がん剤の製造方法
AU2004238625A1 (en) Glyoxalase inhibitors
JP5722233B2 (ja) 抗がん剤の製造方法
EP1958951A1 (en) Phosphine transition metal complex, method for producing same and antitumor agent containing same
JP6802232B2 (ja) ホスフィン遷移金属錯体、その製造方法及び抗がん剤
Erker et al. Structures and dynamic features of dinuclear tartratozirconocene complexes
Lim et al. Palladium (II) and platinum (II) complexes containing dimesyloxy-substituted chiral diamines
Can An Approach Towards Theragnostic Receptor Targeting with 5-Cyclopentadienyl Derivatives of the fac-99mTc (CO) 3-and fac-Re (CO) 3-Core

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application